Clinical Trial Methodology
Chapman & Hall/CRC (Verlag)
978-0-367-57715-5 (ISBN)
Now viewed as its own scientific discipline, clinical trial methodology encompasses the methods required for the protection of participants in a clinical trial and the methods necessary to provide a valid inference about the objective of the trial. Drawing from the authors’ courses on the subject as well as the first author’s more than 30 years working in the pharmaceutical industry, Clinical Trial Methodology emphasizes the importance of statistical thinking in clinical research and presents the methodology as a key component of clinical research.
From ethical issues and sample size considerations to adaptive design procedures and statistical analysis, the book first covers the methodology that spans every clinical trial regardless of the area of application. Crucial to the generic drug industry, bioequivalence clinical trials are then discussed. The authors describe a parallel bioequivalence clinical trial of six formulations incorporating group sequential procedures that permit sample size re-estimation. The final chapters incorporate real-world case studies of clinical trials from the authors’ own experiences. These examples include a landmark Phase III clinical trial involving the treatment of duodenal ulcers and Phase III clinical trials that contributed to the first drug approved for the treatment of Alzheimer’s disease.
Aided by the U.S. FDA, the U.S. National Institutes of Health, the pharmaceutical industry, and academia, the area of clinical trial methodology has evolved over the last six decades into a scientific discipline. This guide explores the processes essential for developing and conducting a quality clinical trial protocol and providing quality data collection, biostatistical analyses, and a clinical study report, all while maintaining the highest standards of ethics and excellence.
Karl E. Peace is the Georgia Cancer Coalition Distinguished Cancer Scholar, founding director of the Center for Biostatistics, and professor of biostatistics in the Jiann-Ping Hsu College of Public Health at Georgia Southern University. Din Chen is the Karl E. Peace Endowed Eminent Scholar Chair in Biostatistics and professor of biostatistics in the Jiann-Ping Hsu College of Public Health at Georgia Southern University.
Overview of Clinical Trial Methodology. Overview of the Drug Development Process and Regulation of Clinical Trials. Ethical Considerations in the Design and Conduct of Clinical Trials. Sample Size Considerations in Clinical Trials Pre-Market Approval. Sequential, Group Sequential, Stochastic Curtailment, and Adaptive Design Procedures in Clinical Trials. Biostatistical Aspects of the Protocol. The Statistical Analysis Plan. Pooling of Data from Multicenter Clinical Trials. Validity of Statistical Inference. Bioequivalence Clinical Trials. Dose and Frequency Determination from Phase II Clinical Trials in Stress Test-Induced Angina. Confirmation of Clinically Optimal Dosing in the Treatment of Duodenal Ulcers: A Phase III Dose Comparison Trial. Pivotal Proof-of-Efficacy Clinical Trials in the Prevention of NANSAID-Induced Gastric Ulceration. Clinical Trials in the Treatment of Alzheimer’s Disease Based upon Enrichment Designs. A Clinical Trial to Establish Reduction of CHD Risk. Pivotal Proof-of-Efficacy Clinical Trials in the Treatment of Panic Disorder. Combination Clinical Trials. Monitoring Clinical Trials for Adverse Events. Index.
| Erscheinungsdatum | 01.07.2020 |
|---|---|
| Reihe/Serie | Chapman & Hall/CRC Biostatistics Series |
| Sprache | englisch |
| Maße | 156 x 234 mm |
| Gewicht | 453 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| Naturwissenschaften ► Biologie | |
| Technik | |
| ISBN-10 | 0-367-57715-1 / 0367577151 |
| ISBN-13 | 978-0-367-57715-5 / 9780367577155 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
